Login to Your Account



Japanese Stocks Lose Buoyancy After Heady Gains in Early 2013

By Cornelia Zou
Contributing Writer

Wednesday, November 13, 2013

HONG KONG – Japan’s biotech stocks have fallen from the precipitous heights they reached through the first half of the year, coming down from a bubble that was driven by a combination of a cheap currency, government stimulus, a new health care policy and a Nobel Prize.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription